Polycystic Kidney Disease

NCT01988038
Study Type: Observational [Patient Registry] Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 20 Years

Official Title: Repository Study of Autosomal Dominant Polycystic Kidney Disease

Eligibility
Ages Eligible for Study: ≥18 years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Sponsors and Collaborators
The Rogosin Institute
Weill Medical College of Cornell University
New York Presbyterian Hospital

Contact: Ines Chicos, BS 212-746-3541 inc9012@nyp.org
NCT01377246
Study Type: Interventional
Study Design: Allocation: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Official Title: A Prospective, Randomized, Double-Blind, Placebo Controlled Clinical Trial to Assess the Effects of Long-Acting Somatostatin (Octreotide Lar) Therapy on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and Moderate to Severe Renal Insufficiency

Ages Eligible for Study: 18 to 75 years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Sponsors and Collaborators
Mario Negri Institute for Pharmacological Research

Contact: Norberto Perico, MD 0039 035 45351 norberto.perico@marionegri.it